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Summary The expression of 5T4, an oncotrophoblast cell surface antigen was examined in 72 colorectal and
27 gastric carcinomas, with immunoperoxidase technique, on frozen sections.
Highly significant association was found between 5T4 expression in the malignant cells and metastatic
spread. The results suggest that the appearance of 5T4 molecules in cancer cells reflects a change which may
contribute to the development of metastatic potential.
It has been shown that certain human tumour tissues and cell
lines express membrane antigens otherwise found only on
placental trophoblast and absent on normal tissues (e.g. Loke
et al., 1980; McLaughlin et al., 1982). These proteins may
exist to protect the semi-allogeneic foetus from immuno-
logical rejection and in a similar way allow tumour cells to
evade host immunity. An improvement of understanding the
role of these antigens in human cancer is likely to be the
basis for achieving new approaches to both its identification
and treatment.
The 5T4 trophoblast cell surface antigen (Hole & Stern,
1988; 1990) shows a restricted pattern of expression in nor-
mal human tissues, but the antigen is present in a wide
variety of transformed cell lines (Hole & Stern, 1988) and
carcinomas (Southall et al., 1990; Jones et al., 1990). In these
investigations of 5T4 antigen expression in limited numbers
of different human carcinomas, no conclusions could be
drawn as to possible correlations with established prognostic
factors.
The objective of the present study was to determine the
relationship between 5T4 expression, tumour growth and
stage of disease, in order to investigate the difference, if any,
between 5T4 positive and negative carcinomas from the
colon and stomach.
Materials and methods
Seventy-two colorectal and 27 gastric carcinomas were
included in this study. Gastric specimens and 33 colorectal
cancers were obtained at the Pomeranian Medical Academy,
Szczecin, Poland, the other colorectal neoplasms were from
various Departments of Surgery, Manchester. The histolog-
ical type and stage of tumour (Table II) as well as the
grading (Table III) were assessed from routine examination
of paraffin-embedded sections, stained with haematoxylin
and eosin. The stage of grouping was made according to the
criteria of Dukes and to the criteria of the Japanese Research
Society, for colorectal and gastric cancer respectively.
Tissue preparation
Biopsy samples were obtained at surgery or endoscopy. The
tissue was immediately embedded in OCT compound, frozen
in liquid nitrogen and subsequently stored in - 70C.
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Immunohistochemistry
A three-stage immunoperoxidase technique was used. Briefly,
slides were incubated alternately with 5T4 murine mono-
clonal antibody (5T4 B8, IgGI; Hole & Stern, 1988) diluted
1/20 for 1 h, biotinylated rabbit anti-mouse antibodies dilut-
ed 1/400 for 30 min (DAKO Ltd) and streptavidin HRP-con-
jugated reagent diluted 1/800 for 30 min. Peroxidase was
visualised using a solution of diaminobenzidine tetrahydro-
chloride (DAB Sigma) in TBS containing 0.03% hydrogen
peroxide. Positive (monoclonal anti-cytokeratin antibody,
LP34, DAKO Ltd.) and negative controls (omission of the
primary antibody) were run in each test. Placental villous
sections were included in each experiment to ensure that the
procedure was working optimally.
Statistical analysis
The distribution of 5T4 antigen was compared with tumour
grade and stage of disease. Statistical analysis was done with
chi-square test, using significance level of 0.05.
Results
The results of immunohistochemical evaluation are summar-
ised in Table I. Overall the proportion of tumour specimens
labelled with mAb 5T4 was 85% for colorectal and 81% for
gastric carcinoma. However, there were two distinct patterns
of immunohistochemical staining, either detection of positive
labelling of the malignant cells and surrounding stroma (40%
of colorectal and 56% of the gastric tumours) or strong
positive reactivity of stromal elements alone (45% of colorec-
tal and 26% of gastric tumours). When the tumour cells were
labelled for 5T4 antigen, there was reactivity in all or nearly
all malignant cells as evidenced by congruency with cyto-
keratin labelling. Only 11 colorectal and three gastric car-
cinomas showed a focal reactivity. The cellular localisation
appeared to be mostly membranous; only in three colorectal
and one gastric cancer was labelling principally cytoplasmic.
For stromal labelling, the intensity of expression diminished
with distance from the tumour cells. In normal colorectal and
gastric epithelium 5T4 antigen was not detected although a
weak expression in the stroma was observed in nine out of 30
specimens. In normal gastric and colonic tissue adjacent to
carcinoma, mucous glands were also weakly positive.
A positive correlation is observed between 5T4 expression
in cancer cells and the stage of disease (Table II). The 5T4
positive staining of malignant cells is more frequent in
tumours from patients presenting with lymph-node or distal
metastases while 5T4 negative neoplasms surrounded by posi-
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Table I Colorectal and gastric tissues staining with murine mono-
clonal antibody, 5T4 B8
ST4+ (n)
No. Tumour cells Stroma
Histology examined and stroma only ST4- (n)
Colorectal adeno- 72 29 (40%) 32 (45%) 11 (15%)
carcinoma
Gastric adeno- 27 15 (56%) 7 (26%) 5 (18%)
carcinoma
Normal colonic and 30 0 9 (weak) 21
gastric tissue
tive reacting stroma or 5T4 negative tumours, are usually
from patients with localised carcinomas. Thus 65% of the
patients with either colorectal or gastric cancer whose
tumour cells are labelled for 5T4 antigen had metastases
while only 23% of patients with localised disease exhibited
tumour labelling. This is statistically significant when com-
paring the frequency of tumour cell positive labelling vs
stroma positive and completely negative tumours in colo-
rectal/gastric (P<0.001) and colorectal cancer (P<0.001).
The same trend is seen in the gastric tumours considered
separately although the difference does not reach statistical
significance.
In colorectal cancer the proportion ofcarcinomas with 5T4
positive staining in tumour cells increases with disease pro-
gression indicated by the staging (P<0.001). 5T4 expression
in cancer cells does not correlate with tumour grade (Table
III).
Table II The relationship between the expression of5T4 antigen and
stage ofdisease
5T4+ (n)
No. Tumour cells Stroma
Stage ofdisease examined and stroma only 5T4- (n)
Colorectal carcinoma
A 8 2 5 1
B 34 7 19 8
C 21 13 7 1
D 9 7 1 1
ap = 0.001
Metastases
negative 42 9 (21%) 24 9
positive 30 20 (67%) 8 2
bp<0.001
Gastric carcinoma
I 2 1 1 -
II 4 1 2 1
III 1 1 - -
IV 20 12 4 4
aNS
Metastases
negative 6 2 (33%) 3 1
positive 21 13 (62%) 4 4
bp = 0.36
NS
All tumours examined
Metastases
negative 48 11 (23%) 27 10
positive 51 33 (65%) 12 6
bp<0.001
aComparing stage of cancer for 5T4 positive tumours to stroma
positive and negative tumours. bComparing 5T4 positive cancer to
stroma positive and negative cancers with or without metastases.
Table III Relationship between 5T4 expression and tumour grade
ST4+ (n)
No. Twnour cells Stroma
Histology examined and stroma only ST4- (n)
Colorectal carcinoma
Well differentiated 18 7 8 3
Moderately 49 21 22 6
differentiated
Poorly differentiated 5 1 2 2
NS
Gastric carcinoma
Intestinal 5 2 3 -
Mixed 2 1 1 -
Diffused 20 12 3 5
NS
NS = not significant.
Discussion
Previous studies of 5T4 tumour expression have not investi-
gated any possible relationship to tumour stage. A new
finding of our study is that the expression of 5T4 antigen in
cancer cells correlates with metastatic spread. This associa-
tion suggests that appearance of this molecule reflects a
change in tumour that may contribue to the development of
metastatic capacity. The origin of the significant stromal
labelling specifically associated with malignancy remains to
be determined. It is tempting to speculate that the 5T4
molecules are produced by the tumour cells at low levels and
subsequently accumulate in the surrounding stroma in the
early stages of cancer.
Other studies have indicated changes in expression of
several cell surface glycoproteins in metastasis. Johnson et al.
(1989) demonstrated that the expression of intracellular-
adhesion molecule 1, in human melanoma correlates with
increased risk of metastases. Tandon et al. (1990) described
association between the 323/A3 surface glycoprotein and
poor prognosis in breast cancer. These authors found that
breast carcinomas larger then 2 cm, without oestrogen recep-
tors, which had involved regional lymph nodes, expressed the
323/A3 antigen more frequently than small, localised and
oestrogen receptor positive neoplasms. Investigations on
experimentally induced carcinomas have also demonstrated a
relationship between tumour progression and a change on
the surface of malignant cells (Damen et al., 1991; Nalei et
al., 1990; Heffernan et al., 1989; Dennis et al., 1987).
Our results on a positive correlation of the 5T4 expression
in cancer cells and their metastatic ability may be important
for further therapeutic strategies. The 5T4 mAb is currently
being assessed for tumour localisation and may be a useful
target in immunotherapy. The ultimate exploitation of the
malignancy associated expression of 5T4 molecules in cancer
will be influenced by the type of molecule. Using molecular
biological approaches to isolate the encoding gene for 5T4
molecules will allow the evaluation of possible relationships
to other families of surface molecules such as those with cell
adhesion roles.
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